Viewing Study NCT00336557


Ignite Creation Date: 2025-12-24 @ 6:34 PM
Ignite Modification Date: 2026-01-25 @ 11:42 AM
Study NCT ID: NCT00336557
Status: COMPLETED
Last Update Posted: 2013-10-30
First Post: 2006-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High-Dose Interferon View
None Neutralizing Antibodies View